Interview: Teodoro B. Padilla, Executive Director and Reiner W. Gloor, Adviser, Pharmaceutical and Healthcare Association of the Philippines (PHAP)
23.10.2013
Related Interviews
Interview: Jingle Garcia Diola – Executive Director, Firmlink Pharma,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Interview: Ravinder S. Singha – Managing Director, Firmlink Pharma,…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Interview: Ramon Aristoza Jr. – Acting President & CEO, PhilHealth,…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
Biosimilars / Sandoz CEO Richard Saynor on Five Crucial Market Trends
In conversation at the FT’s Global Pharmaceutical & Biotechnology Conference last month, Sandoz CEO Richard Saynor outlined the current status of the biosimilars industry, the differences between the European and…
Saudi Arabia / Three Key Industry Trends to Watch
Looking to diversify its economy while simultaneously improving its healthcare system, Saudi Arabia has been rolling out incentives for international companies to invest in local manufacturing. Here are three trends…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual conference, and how the US generics and biosimilars industry might…
Latest Report
